A long-acting Factor VIII replacement therapy for haemophilia A from Sobi and Sanofi has been recommended for use by the NHS ...

Pfizer has ended the global commercialisation of its haemophilia B (factor IX deficiency) gene therapy Beqvez, citing soft ...

Dosing is based on the person’s weight and the treatment at list price would cost around £510,000 per year for an adult ...

Pfizer’s anti-TFPI antibody marstacimab has been approved by the FDA to treat haemophilia, becoming the pharma group’s second new therapy for the blood disorder this year. Marstacimab will be ...

Many couples consider lifestyle, nutrition, and timing when trying to conceive. Nevertheless, an important factor is ...

NICE publishes final draft guidance recommending efanesoctocog alfa as an option for treating and preventing bleeding in ...

Former pupils of a school where disabled children were infected with contaminated blood are seeking damages from its trust at ...

Haemophilia A is a rare disorder that means sufferers do not have enough of the clotting factor VIII in their blood or it does not work properly. This means they cannot form strong clots and bleed ...

Effects of a supervised therapeutic exercise program on musculoskeletal health and gait in patients with haemophilia: A pilot study. Haemophilia. 2021 Oct 22. doi:10.1111/hae.14444 Di Minno G, Coppola ...

Each type can also be either Rh-positive (+) or Rh-negative (-), depending on whether they carry the Rh factor protein. Knowing your blood type is critical in emergencies, as receiving the wrong blood ...

The new documentary, with the working title Killer In The Blood: The Boarding School Scandal, will feature victims of the ...

Delhi's Health Minister Pankaj Kumar Singh on Friday accused the previous Aam Aadmi Party (AAP) government in Delhi of ...